Company: SXTPW
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-014334
Chunk: 243

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-14
Form: S-1
Chunk 243
---
January 2024 Pre-Funded Warrants, respectively, resulting in aggregate proceeds to the Company of $ 9,990. On April 1, 2024, the Company entered into an Amendment to the Debt Exchange Agreement with Trevally, LLC (“Trevally”), which amends the original agreement with Trevally (executed in January 2023). Pursuant to the Amendment, Trevally agreed to return 10,000shares of the Company’s common stock, initially issued to Trevally in January 2023 as advance consideration for agreeing to complete the synthesis of research materials for the Company. Trevally returned the previously issued shares for no consideration on April 3, 2024. Trevally delivered the completed research materials to the Company on July 1, 2024. On July 12, 2024, the Company entered into an At-the-Market Issuance Sales Agreement (the “ATM Agreement”) with WallachBeth Capital LLC as sales agent, to sell shares of common stock having an aggregate offering price of up to $ 1,253,603from time to time, through an “at the market offering” program (the “ATM Offering”). The offer and sale of shares of common stock from the ATM Offering was made pursuant to the Company’s shelf registration statement on Form S-3 and accompanying base prospectus (Registration Statement No. 333-280796) contained therein which became effective on July 18, 2024. The prospectus supplement was subsequently amended on July 22, 2024, July 24, 2024, July 26, 2024, and August 2, 2024, to increase the maximum aggregate offering price under the ATM Agreement to $ 1,774,640, $ 1,890,705, $ 2,190,416, and $ 2,295,192, respectively. From July 19, 2024 to August 1, 2024, the Company sold a total of 677,819shares in the ATM Offering, for gross proceeds of $ 1,994,583. On July 22, 2024 and July 26, 2024, the Company converted 1,291and 1,032shares of Series A Preferred Stock, respectively, held by Knight Therapeutics Inc. into 40,000shares and 33,334shares of common stock, respectively. (b) Common Stock Warrants As of September 30, 202